My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 197

    1.

    Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

    Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR.

    Diabetes Care. 2005 May;28(5):995-1000.PMID: 15855556 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

    Jermendy G; Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, Karve S, Engel S, Balkrishnan R.

    Health Qual Life Outcomes. 2008 Oct 31;6:88.PMID: 18976457 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

    Riedel AA, Heien H, Wogen J, Plauschinat CA.

    Am J Manag Care. 2007 Aug;13(8):457-63.PMID: 17685826 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.

    Duckworth W, Marcelli M, Padden M, Kellick K, Duhancik T, Wilhardt M, Colgan K, Romie A.

    J Manag Care Pharm. 2003 May-Jun;9(3):256-62.PMID: 14613469 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

    Riedel AA, Heien H, Wogen J, Plauschinat CA.

    Pharmacotherapy. 2007 Aug;27(8):1102-10.PMID: 17655510 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus]

    Rodríguez A, Reviriego J, Polavieja P, Mesa J.

    Med Clin (Barc). 2008 Nov 29;131(19):721-30. Spanish. PMID: 19091199 [PubMed - indexed for MEDLINE]Related articles

    7.

    Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy.

    Nichols GA, Koo YH, Shah SN.

    J Gen Intern Med. 2007 Apr;22(4):453-8.PMID: 17372792 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Contemporary analysis of secondary failure of successful sulfonylurea therapy.

    Nichols GA, Alexander CM, Girman CJ, Kamal-Bahl SJ, Brown JB.

    Endocr Pract. 2007 Jan-Feb;13(1):37-44.PMID: 17360299 [PubMed - indexed for MEDLINE]Related articles

    9.

    Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.

    Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D.

    Diabetes Obes Metab. 2008 Jun;10 Suppl 1:8-15.PMID: 18435669 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

    Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD.

    Diabetes Care. 2005 May;28(5):1083-91.PMID: 15855571 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy.

    Schwarz B, Gouveia M, Chen J, Nocea G, Jameson K, Cook J, Krishnarajah G, Alemao E, Yin D, Sintonen H.

    Diabetes Obes Metab. 2008 Jun;10 Suppl 1:43-55.PMID: 18435673 [PubMed - indexed for MEDLINE]Related articles

    12.

    Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

    Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    14.

    Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care.

    Cook MN, Girman CJ, Stein PP, Alexander CM.

    Diabet Med. 2007 Apr;24(4):350-8. Epub 2007 Feb 28.PMID: 17335466 [PubMed - indexed for MEDLINE]Related articles

    15.

    Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?

    Kirk JK, Pearce KA, Michielutte R, Summerson JH.

    J Fam Pract. 1999 Nov;48(11):879-82.PMID: 10907625 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glycemic response to newly initiated diabetes therapies.

    Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, Selby JV.

    Am J Manag Care. 2007 Nov;13(11):598-606.PMID: 17988185 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

    Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

    Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.

    Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA.

    J Manag Care Pharm. 2006 Jul-Aug;12(6):466-71.PMID: 16925454 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone.

    Hamann A, Garcia-Puig J, Paul G, Donaldson J, Stewart M.

    Exp Clin Endocrinol Diabetes. 2008 Jan;116(1):6-13. Epub 2007 Dec 20.PMID: 18095238 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

    Lewin A, Lipetz R, Wu J, Schwartz S.

    Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity